 |
Beware
the silent assassin – Diabetes UK launches hard-hitting ad campaign |
| |
The advertising campaign, developed by The Gate,
will include a series of outdoor posters as well as newspaper and
consumer magazine advertising during October and November 2008
(Diabetes UK) |
| |
|
|
CD28/CD154
Blockade Prevents Autoimmune Diabetes by Inducing Nondeletional
Tolerance After Effector T-Cell Inhibition and Regulatory T-Cell
Expansion |
| |
Immunotherapies that selectively suppress effector
T-cells while permitting the development of natural regulatory
mechanisms may have a unique role in establishing targeted long-standing
immune protection and peripheral tolerance (Diabetes) |
| |
|
|
Postpartum
Screening for Diabetes After a Gestational Diabetes Mellitus–Affected Pregnancy |
| |
Postpartum glucose testing in women with GDM-affected
pregnancies increased over time. However, even in recent years,
42% of women with GDM-affected pregnancies failed to have a postpartum
FPG test, and no test was ordered for 21% of GDM-affected pregnancies
(Obstetrics & Gynecology) |
| |
|
|
Prevalence
of abnormal glucose metabolism in atrial fibrillation: a case
control study in 75-year old subjects |
| |
Atrial fibrillation is associated with chronic
hyperglycaemia amongst 75-year old subjects. Prediabetes and DM
should be pro-actively assessed if AF duration >= 5 years (Cardiovascular Diabetology) |
| |
|
|
VIVUS
Announces the Weight Loss Effects of Qnexa in Type 2 Diabetes |
| |
Presentation at the Obesity Society Annual Scientific
Meeting Shows Weight Loss of 17 Pounds in 28 Weeks (MarketWatch) |
| |
|
|
A
diet pill? Put it down to fat chance |
| |
A collaboration between six Melbourne institutions
could result in a pill that eliminates obesity and diabetes (The
Age, Australia) |
| |
|
|
iSense
and Their “Glycemic Signature” |
| |
What’s new and different with
the iSense system versus the current CGM models that have recently
hit the market are two things: the special flexible micro-wire
technology of their sensor, and the sophisticated data reporting
system they’re developing, which they call The Glycemic Signature (Diabetes mine) |
| |
|
